ICT&health February 22, 2021
The great momentum being generated by Digital Therapeutics (DTx) in North America and Europe is second to no other digital health segment today. Indeed, the ripple effects emanating from the German DiGA Framework are already being felt in Belgium, Spain, and Italy, with more countries to come.
Furthermore, the addition of a €5.1B EU-financial boost to accelerate digital innovation, and interoperability adoption makes Europe the new Digital Health Mecca for 2021 and beyond. However, with so much funding, innovation, and encouraging policies, the responsibility is also to prove positive socio-economic impact and health outcomes.
Pit-Stop
As DTx is still taking baby steps to higher maturity and adoption levels, it’s a good time for a pit-stop to reassess the broader DTx...